These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 8984607

  • 1. [Therapy of hepatocellular carcinoma].
    Allgaier HP, Deibert P, Blum U, Spangenberg HC, Moser E, Blum HE.
    Schweiz Med Wochenschr; 1996 Nov 16; 126(46):1984-94. PubMed ID: 8984607
    [Abstract] [Full Text] [Related]

  • 2. [Hepatocellular carcinoma: npn-surgical treatment].
    Allgaier HP, Deibert P, Becker G, Blum HE.
    Praxis (Bern 1994); 1998 Oct 28; 87(44):1466-70. PubMed ID: 9847686
    [Abstract] [Full Text] [Related]

  • 3. [SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma].
    Numata K, Tanaka K, Kiba T, Saito S, Morita K, Kitamura T, Kondo M, Morimoto M, Shirato K, Hori A, Shimamura T, Isozaki T, Arata S, Okazaki H, Fujii T, Sekihara H.
    Gan To Kagaku Ryoho; 1998 Feb 28; 25 Suppl 1():141-5. PubMed ID: 9512702
    [Abstract] [Full Text] [Related]

  • 4. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 28; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 5. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM, Sala M, Bruix J.
    Liver Transpl; 2000 Nov 28; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of transarterial embolization combined with percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma].
    Shimamura T, Une Y, Nakajima Y, Sato N, Matsushita M, Kamiyama T, Uchino J.
    Gan To Kagaku Ryoho; 1994 Sep 28; 21(13):2229-32. PubMed ID: 7944447
    [Abstract] [Full Text] [Related]

  • 7. [Nonsurgical therapy of focal liver lesions].
    Allgaier HP, Deibert P, Blum HE.
    Praxis (Bern 1994); 1997 Jan 21; 86(4):86-90. PubMed ID: 9064724
    [Abstract] [Full Text] [Related]

  • 8. A new look in the management of unresectable primary hepatocellular carcinoma.
    Lygidakis NJ, Savanis G, Konstantinidou AE, Markidou S, Touloupakis E, Pavlis T, Saleh M, Eftichidou E, Stringaris K, Tavernaraki A.
    Hepatogastroenterology; 1992 Dec 21; 39(6):577-83. PubMed ID: 1336477
    [Abstract] [Full Text] [Related]

  • 9. Treatment of hepatocellular carcinoma.
    Blum HE.
    Best Pract Res Clin Gastroenterol; 2005 Feb 21; 19(1):129-45. PubMed ID: 15757809
    [Abstract] [Full Text] [Related]

  • 10. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)].
    Tanikawa K.
    Gan To Kagaku Ryoho; 1989 Jan 21; 16(1):34-9. PubMed ID: 2536269
    [Abstract] [Full Text] [Related]

  • 11. [Multimodal therapy concepts in hepatocellular carcinoma].
    Bismuth H.
    Zentralbl Chir; 2000 Jan 21; 125(7):647-9. PubMed ID: 10960977
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Jan 21; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 13. [Chemoembolization in the treatment of hepatocarcinoma].
    Figueras J, Valls C, Pamies JJ, Benasco C, Sancho C, Rafecas A, Domínguez J, Torras J, Fabregat J, Baliellas C.
    Rev Esp Enferm Dig; 1993 Jan 21; 83(1):21-5. PubMed ID: 8383990
    [Abstract] [Full Text] [Related]

  • 14. [Advanced hepatocellular carcinoma: therapeutic results in 110 patients and therapeutic strategy].
    Inoue Y, Ishida T, Murakami T, Nakamura H.
    Gan To Kagaku Ryoho; 1998 Oct 21; 25(12):1857-64. PubMed ID: 9797808
    [Abstract] [Full Text] [Related]

  • 15. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H, Ushiyama T, Ishimura K, Izuishi K, Karasawa Y, Masaki T, Watanabe S, Kuriyama S, Maeta H.
    J Surg Oncol; 2003 Feb 21; 82(2):98-103. PubMed ID: 12561065
    [Abstract] [Full Text] [Related]

  • 16. [Nonsurgical therapy methods in hepatocellular carcinoma].
    Wettstein M, Häussinger D.
    Praxis (Bern 1994); 2001 Jan 11; 90(1-2):15-20. PubMed ID: 11206095
    [Abstract] [Full Text] [Related]

  • 17. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan.
    Gastroenterology; 2006 Aug 11; 131(2):461-9. PubMed ID: 16890600
    [Abstract] [Full Text] [Related]

  • 18. Transcatheter arterial embolization for advanced hepatocellular carcinoma resulting in a curative resection: report of two cases.
    Mizoe A, Yamaguchi J, Azuma T, Fujioka H, Furui J, Kanematsu T.
    Hepatogastroenterology; 2000 Aug 11; 47(36):1706-10. PubMed ID: 11149037
    [Abstract] [Full Text] [Related]

  • 19. Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation.
    Troisi R, Defreyne L, Hesse UJ, Praet M, Decruyenaere J, De Hemptinne B.
    Clin Transplant; 1998 Aug 11; 12(4):313-9. PubMed ID: 9686325
    [Abstract] [Full Text] [Related]

  • 20. [Effectiveness and timing of one shot transarterial infusion and/or transcatheter arterial embolization therapy for recurrence of postoperative hepatocellular carcinoma].
    Katsumata T, Fukai S, Utsunomiya T.
    Gan To Kagaku Ryoho; 1991 Aug 11; 18(11):1903-7. PubMed ID: 1652228
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.